Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866303
Max Phase: Preclinical
Molecular Formula: C16H14ClN5O9S2
Molecular Weight: 519.90
Molecule Type: Unknown
Associated Items:
ID: ALA4866303
Max Phase: Preclinical
Molecular Formula: C16H14ClN5O9S2
Molecular Weight: 519.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc(/C(=N/OCC(=O)O)C(=O)N[C@@H]2C(=O)N3[C@@H]2SC[C@@H]2CC(=O)O[C@@]23C(=O)O)c(Cl)s1
Standard InChI: InChI=1S/C16H14ClN5O9S2/c17-10-7(20-15(18)33-10)8(21-30-2-5(23)24)11(26)19-9-12(27)22-13(9)32-3-4-1-6(25)31-16(4,22)14(28)29/h4,9,13H,1-3H2,(H2,18,20)(H,19,26)(H,23,24)(H,28,29)/b21-8-/t4-,9+,13+,16+/m0/s1
Standard InChI Key: ODTKLVLHXPPREX-JQKXTGDSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 519.90 | Molecular Weight (Monoisotopic): 518.9921 | AlogP: -1.07 | #Rotatable Bonds: 7 |
Polar Surface Area: 210.81 | Molecular Species: ACID | HBA: 12 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.87 | CX Basic pKa: 2.57 | CX LogP: -0.23 | CX LogD: -6.52 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.15 | Np Likeness Score: 0.02 |
1. Sato J, Kusano H, Aoki T, Shibuya S, Yokoo K, Komano K, Oguma T, Matsumoto S, Sato T, Yasuo K, Yamawaki K.. (2021) A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships., 46 [PMID:34450571] [10.1016/j.bmc.2021.116343] |
Source(1):